2021 U.S.-Booked Air Volume: $22.3 million

U.S.-booked air spend for pharmaceutical and medical device provider Abbott decreased slightly from 2020 to 2021, according to a BTN estimate. The 2021 figure represents less than a quarter of the company’s 2019 volume, which came in at $104 million.

The company’s global revenue increased to $43.1 billion in 2021, a 24 percent increase from 2020. In 2021, Abbott employed a workforce of some 113,000, an increase of about 4,000 from a year prior. The company recently expanded its manufacturing facilities in Ireland, with an additional 1,000 employees.

While Abbott continued to employ a strict travel policy, avoiding non-essential business travel, its ‘Travel Safety’ program supported 28,000 travelers in 2021. In 2021, the company saw a 55 percent decrease in business travel-associated) carbon emissions compared to 2019 levels, but a 9 percent increase from 2020.